These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15907588

  • 1. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates.
    Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K.
    J Control Release; 2005 May 18; 104(2):397-413. PubMed ID: 15907588
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H, Yamashita S, Mori Y, Hayashi Y, Motoyama K, Hattori K, Takeuchi T, Jono H, Ando Y, Hirayama F, Uekama K.
    J Control Release; 2010 Aug 17; 146(1):106-17. PubMed ID: 20678990
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
    Arima H, Chihara Y, Arizono M, Yamashita S, Wada K, Hirayama F, Uekama K.
    J Control Release; 2006 Nov 17; 116(1):64-74. PubMed ID: 17083992
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
    Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K.
    Bioconjug Chem; 2003 Nov 17; 14(2):342-50. PubMed ID: 12643744
    [Abstract] [Full Text] [Related]

  • 5. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H, Arizono M, Higashi T, Yoshimatsu A, Ikeda H, Motoyama K, Hattori K, Takeuchi T, Hirayama F, Uekama K.
    Cancer Gene Ther; 2012 May 17; 19(5):358-66. PubMed ID: 22402627
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
    Hayashi Y, Higashi T, Motoyama K, Mori Y, Jono H, Ando Y, Arima H.
    J Drug Target; 2013 May 17; 21(5):487-96. PubMed ID: 23570609
    [Abstract] [Full Text] [Related]

  • 10. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
    Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K.
    Bioconjug Chem; 2002 May 17; 13(6):1211-9. PubMed ID: 12440855
    [Abstract] [Full Text] [Related]

  • 11. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA.
    Motoyama K, Hayashida K, Higashi T, Arima H.
    Bioorg Med Chem; 2012 Feb 15; 20(4):1425-33. PubMed ID: 22277591
    [Abstract] [Full Text] [Related]

  • 12. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo.
    Anno T, Higashi T, Motoyama K, Hirayama F, Uekama K, Arima H.
    J Drug Target; 2012 Apr 15; 20(3):272-80. PubMed ID: 22201459
    [Abstract] [Full Text] [Related]

  • 13. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H, Yoshimatsu A, Ikeda H, Ohyama A, Motoyama K, Higashi T, Tsuchiya A, Niidome T, Katayama Y, Hattori K, Takeuchi T.
    Mol Pharm; 2012 Sep 04; 9(9):2591-604. PubMed ID: 22873579
    [Abstract] [Full Text] [Related]

  • 14. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages.
    Hashimoto M, Morimoto M, Saimoto H, Shigemasa Y, Yanagie H, Eriguchi M, Sato T.
    Biotechnol Lett; 2006 Jun 04; 28(11):815-21. PubMed ID: 16786247
    [Abstract] [Full Text] [Related]

  • 15. [Polyfection as nonviral gene transfer method -design of novel nonviral vector using alpha-cyclodextrin].
    Arima H.
    Yakugaku Zasshi; 2004 Jul 04; 124(7):451-64. PubMed ID: 15235229
    [Abstract] [Full Text] [Related]

  • 16. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
    Motoyama K, Mitsuyasu R, Akao C, Abu Hashim II, Sato N, Tanaka T, Higashi T, Arima H.
    Mol Pharm; 2015 Sep 08; 12(9):3129-36. PubMed ID: 26270769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
    Anno T, Higashi T, Hayashi Y, Motoyama K, Jono H, Ando Y, Arima H.
    J Drug Target; 2014 Dec 08; 22(10):883-90. PubMed ID: 25051178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.